Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah Jarvis is active.

Publication


Featured researches published by Deborah Jarvis.


The Lancet | 2008

Rhinitis and onset of asthma: a longitudinal population-based study

Rafea Shaaban; Mahmoud Zureik; David Soussan; Catherine Neukirch; Joachim Heinrich; Jordi Sunyer; Matthias Wjst; Isa Cerveri; Isabelle Pin; Jean Bousquet; Deborah Jarvis; Peter Burney; Françoise Neukirch; Bénédicte Leynaert

BACKGROUNDnA close relation between asthma and allergic rhinitis has been reported by several epidemiological and clinical studies. However, the nature of this relation remains unclear. We used the follow-up data from the European Community Respiratory Health Survey to investigate the onset of asthma in patients with allergic and non-allergic rhinitis during an 8.8-year period.nnnMETHODSnWe did a longitudinal population-based study, which included 29 centres (14 countries) mostly in western Europe. Frequency of asthma was studied in 6461 participants, aged 20-44 years, without asthma at baseline. Incident asthma was defined as reporting ever having had asthma confirmed by a physician between the two surveys. Atopy was defined as a positive skin-prick test to mites, cat, Alternaria, Cladosporium, grass, birch, Parietaria, olive, or ragweed. Participants were classified into four groups at baseline: controls (no atopy, no rhinitis; n=3163), atopy only (atopy, no rhinitis; n=704), non-allergic rhinitis (rhinitis, no atopy; n=1377), and allergic rhinitis (atopy+rhinitis; n=1217). Cox proportional hazards models were used to study asthma onset in the four groups.nnnFINDINGSnThe 8.8-year cumulative incidence of asthma was 2.2% (140 events), and was different in the four groups (1.1% (36), 1.9% (13), 3.1% (42), and 4.0% (49), respectively; p<0.0001). After controlling for country, sex, baseline age, body-mass index, forced expiratory volume in 1 s (FEV(1)), log total IgE, family history of asthma, and smoking, the adjusted relative risk for asthma was 1.63 (95% CI 0.82-3.24) for atopy only, 2.71 (1.64-4.46) for non-allergic rhinitis, and 3.53 (2.11-5.91) for allergic rhinitis. Only allergic rhinitis with sensitisation to mite was associated with increased risk of asthma independently of other allergens (2.79 [1.57-4.96]).nnnINTERPRETATIONnRhinitis, even in the absence of atopy, is a powerful predictor of adult-onset asthma.


Thorax | 2010

Early life origins of chronic obstructive pulmonary disease

Cecilie Svanes; Jordi Sunyer; Estel Plana; Shyamali C. Dharmage; Joachim Heinrich; Deborah Jarvis; R. de Marco; Dan Norbäck; Chantal Raherison; Simona Villani; Matthias Wjst; Knut Svanes; J. M. Anto

Background: Early life development may influence subsequent respiratory morbidity. The impact of factors determined in childhood on adult lung function, decline in lung function and chronic obstructive pulmonary disease (COPD) was investigated. Methods: European Community Respiratory Health Survey participants aged 20–45 years randomly selected from general populations in 29 centres underwent spirometry in 1991–3 (nu200a=u200a13u2009359) and 9 years later (nu200a=u200a7738). Associations of early life factors with adult forced expiratory volume in 1 s (FEV1), FEV1 decline and COPD (FEV1/FVC ratio <70% and FEV1 <80% predicted) were analysed with generalised estimating equation models and random effects linear models. Results: Maternal asthma, paternal asthma, childhood asthma, maternal smoking and childhood respiratory infections were significantly associated with lower FEV1 and defined as “childhood disadvantage factors”; 40% had one or more childhood disadvantage factors which were associated with lower FEV1 (men: adjusted difference 95 ml (95% CI 67 to 124); women: adjusted difference 60 ml (95% CI 40 to 80)). FEV1 decreased with increasing number of childhood disadvantage factors (⩾3 factors, men: 274 ml (95% CI 154 to 395), women: 208 ml (95% CI 124 to 292)). Childhood disadvantage was associated with a larger FEV1 decline (1 factor: 2.0 ml (95% CI 0.4 to 3.6) per year; 2 factors: 3.8 ml (95% CI 1.0 to 6.6); ⩾3 factors: 2.2 ml (95% CI −4.8 to 9.2)). COPD increased with increasing childhood disadvantage (1 factor, men: OR 1.7 (95% CI 1.1 to 2.6), women: OR 1.6 (95% CI 1.01 to 2.6); ⩾3 factors, men: OR 6.3 (95% CI 2.4 to 17), women: OR 7.2 (95% CI 2.8 to 19)). These findings were consistent between centres and when subjects with asthma were excluded. Conclusions: People with early life disadvantage have permanently lower lung function, no catch-up with age but a slightly larger decline in lung function and a substantially increased COPD risk. The impact of childhood disadvantage was as large as that of heavy smoking. Increased focus on the early life environment may contribute to the prevention of COPD.


Allergy | 2007

Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I

P. J. Bousquet; S. Chinn; Christer Janson; Manolis Kogevinas; Peter Burney; Deborah Jarvis

Background:u2002 Many studies have reported the prevalence of sensitization using skin prick tests. However, comparisons between studies and between regions are difficult because the number and the type of allergens tested vary widely. Using the European Community Health Respiratory Survey I data, the geographical variation of sensitization to environmental allergen as measured by skin tests was established.


Menopause | 2009

Is age at menopause increasing across Europe? : results on age at menopause and determinants from two population-based studies

Julia Dratva; Francisco Gómez Real; Christian Schindler; Ursula Ackermann-Liebrich; Margaret W. Gerbase; Nicole Probst-Hensch; Cecilie Svanes; Ernst Raidar Omenaas; Françoise Neukirch; Matthias Wjst; Alfredo Morabia; Deborah Jarvis; Bénédicte Leynaert; Elisabeth Zemp

Objective: To investigate the variability and determinants of menopause age in two European cohort studies, the European Respiratory Health Survey and the Swiss Air Pollution and Lung Disease in Adults Cohort. Methods: Age at menopause was estimated in 5,288 women, aged 30 to 60 years, randomly selected in nine European countries between 1998 and 2002. Determinants of natural and surgically induced menopause were investigated by Cox regression and heterogeneity by meta-analysis. Follicle-stimulating hormone and luteinizing hormone levels were assessed in a subsample. Results: A quarter of the women were postmenopausal by age 50.8 years. Median age of natural menopause was 54 years. Hormone levels were within expected ranges for premenopausal and postmenopausal women. Surgically induced menopause was highly prevalent (22%-47%), associated with earlier timing of menopause. Determinants of earlier menopause were current smoking (hazard ratio [HR], 1.59; 95% CI, 1.27-1.98), body mass index greater than 30 kg/m2 (HR, 1.32; 95%, CI, 1.02-1.70), and low physical activity (HR, 1.37; 95%, CI, 1.12-1.67). The determinant for later menopause was multiparity (HR, 0.74; 95% CI, 0.62-0.89). Predictors were similar for naturally and surgically induced menopause. Oral contraceptive use yielded heterogeneous effects on timing of menopause. Later birth was associated with later menopause (HR, 0.934; 95% CI, 0.91-0.96). This evidence of a secular trend is heterogeneous across countries. Conclusions: Age at menopause varies across Europe, shifting toward higher ages. This secular trend seems paradoxical because several adult determinants, that is, overweight, smoking, sedentarity, and nulliparity, associated with early menopause are on the rise in Europe. The heterogeneity of the secular trend suggests additional country-specific factors not included in the study, such as improved childhood nutrition and health, that have an influence on reproductive aging.


Allergy | 2007

The socio-economic burden of asthma is substantial in Europe

Simone Accordini; Angelo Corsico; Isa Cerveri; David Gislason; Amund Gulsvik; Christer Janson; Deborah Jarvis; Alessandro Marcon; Isabelle Pin; P. Vermeire; Enrique Almar; Massimiliano Bugiani; Lucia Cazzoletti; Enric Duran-Tauleria; Rain Jögi; Alessandra Marinoni; Jesús Martínez-Moratalla; Bénédicte Leynaert; R. de Marco

Background: Few data are available on the asthma burden in the general population. We evaluated the level and the factors associated with the asthma burden in Europe.


Allergy | 2008

Quality‐of‐life and asthma‐severity in general population asthmatics: results of the ECRHS II study

Valérie Siroux; Anne Boudier; J. M. Anto; Lucia Cazzoletti; Simone Accordini; J. Alonso; Isa Cerveri; Angelo Corsico; Amund Gulsvik; Deborah Jarvis; R. de Marco; Alessandro Marcon; E. A. Marques; Massimiliano Bugiani; Christer Janson; Bénédicte Leynaert; Isabelle Pin

Background: Health‐related quality‐of‐life (HRQL) has been poorly studied in large samples of asthmatics from the general population. HRQL and its relationship to asthma‐severity were assessed among 900 asthmatics enrolled in the European Community Respiratory Health Survey.


Epidemiology | 2009

Home outdoor NO2 and new onset of self-reported asthma in adults

Bénédicte Jacquemin; Jordi Sunyer; Bertil Forsberg; Inmaculada Aguilera; David Briggs; Raquel Garcia-Esteban; Thomas Götschi; Joachim Heinrich; Bengt Järvholm; Deborah Jarvis; Danielle Vienneau; Nino Künzli

Background: Few studies have investigated new onset of asthma in adults in relation to air pollution. The aim of this study is to investigate the association between modeled background levels of traffic-related air pollution at the subjects’ home addresses and self-reported asthma incidence in a European adult population. Methods: Adults from the European Respiratory Health Survey were included (n = 4185 from 17 cities). Subjects’ home addresses were geocoded and linked to outdoor nitrogen dioxide (NO2) estimates, as a marker of local traffic-related pollution. We obtained this information from the 1-km background NO2 surface modeled in APMoSPHERE (Air Pollution Modelling for Support to Policy on Health and Environmental Risk in Europe). Asthma incidence was defined as reporting asthma in the follow-up (1999 to 2001) but not in the baseline (1991 to 1993). Results: A positive association was found between NO2 and asthma incidence (odds ratio 1.43; 95% confidence interval = 1.02 to 2.01) per 10 &mgr;g/m3. Results were homogeneous among centers (P value for heterogeneity = 0.59). Conclusions: We found an association between a marker of traffic-related air pollution and asthma incidence in European adults.


Allergy | 2008

Assessing skin prick tests reliability in ECRHS-I.

P. J. Bousquet; L. Chatzi; Deborah Jarvis; P. Burney

Introduction:u2002 Atopy, the clinical definition of an immunoglobulin E (IgE) high‐responder, can be documented either by the detection of IgE antibodies in serum or by a positive skin prick test. Epidemiological studies use different reaction sizes to define a skin test reaction as positive or negative. The aim of the study was to identify the best cut‐off level for skin prick tests.


Allergy | 2008

Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I

Philippe-Jean Bousquet; Bénédicte Leynaert; Françoise Neukirch; J Sunyer; Christer Janson; J. M. Anto; Deborah Jarvis; Peter Burney

Background:u2002 No large studies in adults has examined geographical variation in the prevalence of nasal allergy/allergic rhinitis in adults or considered the proportion of reported nasal symptoms on exposure to allergen attributable to atopy. The aim of this report was to describe the geographic distribution of subjects with nasal symptoms who are sensitized as determined by skin prick tests, using data from the European Community Respiratory Health Survey I.


The Journal of Allergy and Clinical Immunology | 2009

Domestic use of hypochlorite bleach, atopic sensitization, and respiratory symptoms in adults

Jan-Paul Zock; Estel Plana; Josep M. Antó; Geza Benke; Paul D. Blanc; Aurelia Carosso; Anna Dahlman-Höglund; Joachim Heinrich; Deborah Jarvis; Hans Kromhout; Linnéa Lillienberg; Maria C. Mirabelli; Dan Norbäck; Mario Olivieri; Michela Ponzio; Katja Radon; Argo Soon; Marc van Sprundel; Jordi Sunyer; Cecilie Svanes; Kjell Torén; Giuseppe Verlato; Simona Villani; Manolis Kogevinas

BACKGROUNDnProfessional use of hypochlorite (bleach) has been associated with respiratory symptoms. Bleach is capable of inactivating allergens, and there are indications that its domestic use may reduce the risk of allergies in children.nnnOBJECTIVEnTo study the associations between household use of bleach and atopic sensitization, allergic diseases, and respiratory health status in adults.nnnMETHODSnWe identified 3626 participants of the European Community Respiratory Health Survey II in 10 countries who did the cleaning in their homes and for whom data on specific serum IgE to 4 environmental allergens were available. Frequency of bleach use and information on respiratory symptoms were obtained in face-to-face interviews. House dust mite and cat allergens in mattress dust were measured in a subsample. Associations between the frequency of bleach use and health outcomes were evaluated by using multivariable mixed logistic regression analyses.nnnRESULTSnThe use of bleach was associated with less atopic sensitization (odds ratio [OR], 0.75; 95% CI, 0.63-0.89). This association was apparent for specific IgE to both indoor (cat) and outdoor (grass) allergens, and was consistent in various subgroups, including those without any history of respiratory problems (OR, 0.85). Dose-response relationships (P < .05) were apparent for the frequency of bleach use and sensitization rates. Lower respiratory tract symptoms, but not allergic symptoms, were more prevalent among those using bleach 4 or more days per week (OR, 1.24-1.49). The use of bleach was not associated with indoor allergen concentrations.nnnCONCLUSIONnPeople who clean their homes with hypochlorite bleach are less likely to be atopic but more likely to have respiratory symptoms.

Collaboration


Dive into the Deborah Jarvis's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jordi Sunyer

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Burney

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

J. M. Anto

Pompeu Fabra University

View shared research outputs
Top Co-Authors

Avatar

Kjell Torén

Sahlgrenska University Hospital

View shared research outputs
Top Co-Authors

Avatar

J Sunyer

Barcelona Biomedical Research Park

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge